RELMADA THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding from Q4 2012 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Relmada Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2012 to Q4 2024.
  • Relmada Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 30.2M shares, a 0.25% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 30.2M +75K +0.25% Dec 31, 2024 10-K 2025-03-27
Q3 2024 30.2M +75K +0.25% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 30.2M +75K +0.25% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 30.2M +75K +0.25% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 30.1M 0 0% Dec 31, 2023 10-K 2025-03-27
Q3 2023 30.1M +1.46M +5.09% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 30.1M +74.6K +0.25% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 30.1M +696K +2.37% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 30.1M +2.36M +8.5% Dec 31, 2022 10-K 2024-03-19
Q3 2022 28.6M +11.1M +63.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 30M +12.6M +71.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 29.4M +12.7M +75.6% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 27.7M +11.4M +69.8% Dec 31, 2021 10-K 2023-03-23
Q3 2021 17.5M +1.31M +8.11% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 17.5M +1.62M +10.2% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 16.7M +1.81M +12.1% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 16.3M +1.88M +13% Dec 31, 2020 10-K 2022-03-25
Q3 2020 16.2M +6.25M +62.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15.9M +6.11M +62.7% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 14.9M -16M -51.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 14.5M -15.3M -51.4% Dec 31, 2019 10-K 2021-03-24
Q3 2019 9.94M -2.61M -20.8% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 9.74M +6.61M +211% Jun 30, 2019 10-K 2021-03-24
Q1 2019 31M +18.4M +147% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 29.8M +17.2M +137% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 12.5M +4.75K +0.04% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 3.14M -9.39M -75% Jun 30, 2018 10-KT 2020-03-26
Q1 2018 12.5M +509K +4.23% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 12.5M +509K +4.23% Dec 31, 2017 10-Q 2018-02-12
Q3 2017 12.5M +509K +4.23% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 12.5M +493K +4.1% Jun 30, 2017 10-K 2018-09-28
Q1 2017 12M +20.8K +0.17% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 12M +36.8K +0.31% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 12M +1.02M +9.28% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 12M +1.26M +11.7% Jun 30, 2016 10-K 2017-09-28
Q1 2016 12M -41.7M -77.6% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 12M -41.7M -77.6% Dec 31, 2015 10-Q 2016-02-05
Q3 2015 11M -32.8M -74.9% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 10.8M +2.72M +33.7% Jun 30, 2015 10-K 2016-09-09
Q1 2015 53.7M +3.86M +7.73% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 53.7M +48.7M +983% Dec 31, 2014 10-Q 2015-02-13
Q3 2014 43.9M Sep 30, 2014 10-Q 2014-11-07
Q2 2014 8.06M Jun 30, 2014 10-K 2015-09-11
Q1 2014 49.9M Mar 31, 2014 8-K 2014-05-27
Q4 2013 4.96M -19.1M -79.4% Dec 31, 2013 10-KT 2014-09-09
Q4 2012 24M Dec 31, 2012 8-K 2014-05-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.